Standard BioTools Inc.
LAB
$1.21
-$0.03-2.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.53% | 23.59% | -26.48% | -- | -- |
| Total Depreciation and Amortization | -4.24% | 5.51% | -37.93% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.62% | -10.83% | 36.36% | -- | -- |
| Change in Net Operating Assets | 106.90% | -294.57% | 174.98% | -- | -- |
| Cash from Operations | 31.75% | -115.40% | 49.55% | 28.63% | 37.50% |
| Capital Expenditure | 62.66% | -49.44% | -49.98% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 49.36% | -35.46% | 206.51% | -- | -- |
| Cash from Investing | 88.07% | -43.15% | 183.30% | -161.45% | -84.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 672.06% | -- | -- |
| Repurchase of Common Stock | -334.78% | -2.22% | 35.71% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 334.78% | 99.92% | -2,725,900.00% | 99.99% | -43.72% |
| Foreign Exchange rate Adjustments | 120.73% | 233.71% | 34.56% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 150.39% | 64.41% | 27.12% | -243.09% | -107.31% |